Skip to content

Research stocks, funds and crypto by ticker or name

Loading

Portside

One living portfolio for stocks, ETFs, options, and crypto.

Product

Portfolio Intelligence Portside Congress trades Super-investors Economic calendar Earnings calendar Pricing

Company

About FAQs Contact Create account

Legal

Privacy Terms Portside rules

© 2026 InstaportInformation and analytics, not investment advice. Connections are read-only.

ABUS stock Fair Value — Arbutus Biopharma Corp filings, insiders & smart money · Instaport

ABUS

Arbutus Biopharma Corp

COMMON STOCK · NASDAQ

Price and daily changeSign in

Earnings12 Nov 2026

52-week rangeSign inDay rangeSign in

Market cap: Sign in
Volume: Sign in
Beta: Sign in
Shares float: Sign in
Short interest: 9.56%
P/E (fwd): Sign in
PEG (fwd): Sign in

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Create free account

Overview Statistics Statements Dividends🔒Momentum🔒Quant🔒Fair Value🔒Earnings Analysts🔒Insiders Smart Money Options🔒Insights🔒

Fair value

Included with Pro.

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Loading evidence for ABUS

Rev growth (fwd)